loading
Papers Papers/2022 Papers Papers/2022

Research.Publish.Connect.

Paper

Paper Unlock

Authors: Melonie Burrows 1 ; Graeme Jahns 1 ; Geoffrey Houlton 1 ; Berry van Gelder 2 and Frank Marcus 3

Affiliations: 1 Heart Force Medical Inc., Canada ; 2 Catharina Hospital, Netherlands ; 3 The University Medical Centre, United States

Keyword(s): Cardiac Resynchronization Therapy, Seismocardiography, Ballistocardiography, Biventricular pacing, Heart failure.

Related Ontology Subjects/Areas/Topics: Biomedical Engineering ; Biomedical Instruments and Devices ; Biomedical Sensors ; Devices ; Electrocardiography and Heart Monitoring ; Emerging Technologies ; Health Monitoring Devices ; Human-Computer Interaction ; Physiological Computing Systems ; Telecommunications ; Wireless and Mobile Technologies ; Wireless Information Networks and Systems

Abstract: Cardiac resynchronization therapy (CRT) results in improved clinical status in patients with heart failure and left ventricular dyssynchrony. One third of CRT patients fail to respond due to the inability to 1) identify non-responders prior to treatment, 2) optimize coronary sinus lead placement for left ventricular pacing and 3) optimize the atrio-ventricular (A-V) and inter-ventricular (V-V) intervals. Although invasive measurements of first maximal derivative of left ventricular pressure (dP/dtmax) are used to optimize lead placement and A-V and V-V intervals in CRT, it would be preferable to have a non-invasive assessment of dP/dtmax. Echocardiographic dyssynchrony and left ventricular function are current parameters for non-invasively evaluating responders to CRT, but they are not recommended due to their poor reproducibility. We applied recent advances in technology to develop a device called the digital ballistocardiograph (dBG®), which assesses the mechanical function of the heart using triaxial accelerometry. We show that dBG® cardiac events are valid in comparison to 2D transthoracic echocardiography and reliable in comparison to cardiac magnetic resonance imaging. We present preliminary data to support our position that the dBG® could be used as a non-invasive assessment of dP/dtmax in heart failure patients to identify responders and optimize CRT. (More)

CC BY-NC-ND 4.0

Sign In Guest: Register as new SciTePress user now for free.

Sign In SciTePress user: please login.

PDF ImageMy Papers

You are not signed in, therefore limits apply to your IP address 44.200.74.73

In the current month:
Recent papers: 100 available of 100 total
2+ years older papers: 200 available of 200 total

Paper citation in several formats:
Burrows, M.; Jahns, G.; Houlton, G.; van Gelder, B. and Marcus, F. (2012). SEISMOCARDIOGRAPHY: A NOVEL APPLICATION FOR THE NON-INVASIVE ASSESSMENT OF THE FIRST MAXIMAL DERIVATIVE OF LEFT VENTRICULAR PRESSURE. In Proceedings of the International Conference on Biomedical Electronics and Devices (BIOSTEC 2012) - BIODEVICES; ISBN 978-989-8425-91-1; ISSN 2184-4305, SciTePress, pages 251-256. DOI: 10.5220/0003845202510256

@conference{biodevices12,
author={Melonie Burrows. and Graeme Jahns. and Geoffrey Houlton. and Berry {van Gelder}. and Frank Marcus.},
title={SEISMOCARDIOGRAPHY: A NOVEL APPLICATION FOR THE NON-INVASIVE ASSESSMENT OF THE FIRST MAXIMAL DERIVATIVE OF LEFT VENTRICULAR PRESSURE},
booktitle={Proceedings of the International Conference on Biomedical Electronics and Devices (BIOSTEC 2012) - BIODEVICES},
year={2012},
pages={251-256},
publisher={SciTePress},
organization={INSTICC},
doi={10.5220/0003845202510256},
isbn={978-989-8425-91-1},
issn={2184-4305},
}

TY - CONF

JO - Proceedings of the International Conference on Biomedical Electronics and Devices (BIOSTEC 2012) - BIODEVICES
TI - SEISMOCARDIOGRAPHY: A NOVEL APPLICATION FOR THE NON-INVASIVE ASSESSMENT OF THE FIRST MAXIMAL DERIVATIVE OF LEFT VENTRICULAR PRESSURE
SN - 978-989-8425-91-1
IS - 2184-4305
AU - Burrows, M.
AU - Jahns, G.
AU - Houlton, G.
AU - van Gelder, B.
AU - Marcus, F.
PY - 2012
SP - 251
EP - 256
DO - 10.5220/0003845202510256
PB - SciTePress